Development
Elevance Health, Inc.
ELV
$393.36
$8.712.26%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -1.04% | -19.59% | 13.19% | 11.18% | -23.92% |
| Total Depreciation and Amortization | -107.14% | -5.54% | 10.18% | 29.05% | -0.80% |
| Total Amortization of Deferred Charges | 14.36% | -- | -- | -- | 23.51% |
| Total Other Non-Cash Items | -62.77% | 842.47% | -2.73% | 37.93% | 7,150.00% |
| Change in Net Operating Assets | -38.81% | -92.49% | -241.99% | 796.90% | -1,853.07% |
| Cash from Operations | -95.72% | -46.93% | -20.47% | 154.58% | -190.79% |
| Capital Expenditure | -9.40% | -4.59% | -18.64% | -18.50% | 12.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 169.23% | 678.57% | 97.63% | -2,585.25% | 23.53% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -217.62% | 51.62% | 73.84% | 1.43% | 203.55% |
| Cash from Investing | -456.06% | 44.91% | 66.80% | -101.77% | 129.92% |
| Total Debt Issued | -80.94% | 75.68% | -107.66% | 142.59% | 119.63% |
| Total Debt Repaid | 141.00% | -174.36% | 89.63% | -17,071.43% | 12.45% |
| Issuance of Common Stock | 33.33% | -13.89% | -5.00% | -43.42% | -28.57% |
| Repurchase of Common Stock | -62.81% | 17.53% | -3.35% | -14.10% | -8.99% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -13.44% | -13.73% | -13.27% | -13.59% | -11.72% |
| Other Financing Activities | -92.00% | -100.00% | -40.00% | -60.00% | 31.58% |
| Cash from Financing | -52.71% | 20.80% | -1,025.98% | -264.91% | 80.38% |
| Foreign Exchange rate Adjustments | -50.00% | 33.33% | 116.67% | 125.00% | 300.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -195.82% | -61.59% | -151.19% | 115.07% | -143.44% |